Answers are grounded in this paper and cite their sources.
In recent years, there has been a growing interest in factor XIII in ischaemic stroke. The study's main aim was to assess the usefulness of factor XIII concentration determination in patients with acute ischaemic stroke (AIS) treated with thrombolysis with recombinant tissue plasminogen activator (t-PA).
No takes yet. Share an insight, caveat, or question.
Wiszniewska et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: